Skip to main content

stock

PLRX · PLIANT THERAPEUTICS, INC.

What PLIANT THERAPEUTICS, INC. reports to the SEC, read from its filings.

Open in the app

Price

The live PLRX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on PLRX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
61,921,897 as of 2026-08-07 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
140.4%
ROA
108.7%

Health

Current ratio
9.9x
Debt/equity
0.0x

Deep value

NCAV
$120.19M
NCAV per share
$1.94
Price/NCAV
Locked
NNWC
-$18.07M
NNWC per share
-$0.29
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$23.86M-$22.37M
10-Q filed 2026-08-11
2026-03-31——Gross profit: unreported by this company.-$21.77M-$20.04M
10-Q filed 2026-08-11
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31——Gross profit: unreported by this company.-$23.58M$275.07M
DEF 14A filed 2026-04-22
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30——Gross profit: unreported by this company.-$28.27M-$26.30M
10-Q filed 2025-11-06
2025-06-30——Gross profit: unreported by this company.-$45.59M-$43.30M
10-Q filed 2026-08-11
2025-03-31——Gross profit: unreported by this company.-$58.94M-$56.17M
10-Q filed 2026-08-11
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$0—Gross profit: unreported by this company.-$53.32M$370.87M
DEF 14A filed 2026-04-22
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$0—Gross profit: unreported by this company.-$62.01M-$57.76M
10-Q filed 2025-11-06
Assembled from more than one filing; the filing above is only the newest of them.
Assets
$189.88M
Equity
$146.93M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$0-$156.37M$149.30M-$128.71M
2024-12-31$0-$228.37M$210.30M-$159.35M
2023-12-31$1.58M-$184.15M$161.30M-$117.28M
2022-12-31$9.69M-$127.20M-$123.32M-$96.39M
2021-12-31$7.57M-$97.53M-$97.26M-$77.40M
2020-12-31$41.82M-$41.65M-$41.53M-$38.80M
2019-12-31$57.05M-$1.23M-$631,000-$3.71M

Company filings

since Mon Mar 30

events

  • Results

    Results
    Aug 118-K
  • Executive or director change

    Executive or director change
    Jul 138-K
  • Shareholder vote results

    Shareholder vote results
    Jun 118-K
  • Results

    Results
    May 118-K
  • Executive or director change

    Executive or director change
    Apr 178-K
  • Other event

    Other event
    Mar 308-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

  • Point72

    Period Tue 30 Jun 2026

    0.0%Trimmed

All funds

News

Stories that named PLRX, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about PLRX.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about PLRX.

nakagai

Signals on PLRX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the PLRX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

PLIANT THERAPEUTICS, INC. (PLRX): SEC filings, financials and insider trades · Nakagai